Evidence map›Paper›PMID 34367072›Full record

ArticleFrontiers in endocrinology2021

Highly Symptomatic Progressing Cardiac Paraganglioma With Intracardiac Extension Treated With

Alexis Huot Daneault, Mélanie Desaulniers, Jean-Mathieu Beauregard, Alexis Beaulieu, Frédéric Arsenault, Geneviève April, Éric Turcotte, François-Alexandre Buteau

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Alexis Huot DaneaultDépartement de médecine nucléaire et radiobiologie, Université de Sherbrooke, Sherbrooke, QC, Canada.
Mélanie DesaulniersDépartement de médecine nucléaire et radiobiologie, Université de Sherbrooke, Sherbrooke, QC, Canada.
Jean-Mathieu BeauregardDépartement d'imagerie médicale, Division médecine nucléaire, CHU de Québec, Québec, QC, Canada.
Alexis BeaulieuDépartement d'imagerie médicale, Division médecine nucléaire, CHU de Québec, Québec, QC, Canada.
Frédéric ArsenaultDépartement d'imagerie médicale, Division médecine nucléaire, CHU de Québec, Québec, QC, Canada.
Geneviève AprilDépartement d'imagerie médicale, Division médecine nucléaire, CHU de Québec, Québec, QC, Canada.
Éric TurcotteDépartement de médecine nucléaire et radiobiologie, Université de Sherbrooke, Sherbrooke, QC, Canada.
François-Alexandre ButeauDépartement d'imagerie médicale, Division médecine nucléaire, CHU de Québec, Québec, QC, Canada.
Centre hospitalier universitaire de Québec · CAUniversité de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Primary cardiac paragangliomas are rare tumors. Metastatic disease is even rarer. Surgical management is technically challenging, and sometimes even impossible. Available therapeutic modalities for metastatic disease include external beam radiation therapy as well as systemic treatments, namely Case Presentation: A 47-year-old man with no medical history consulted for rapidly decreasing exercise tolerance. The investigation demonstrated an unresectable progressing metastatic cardiac paraganglioma with intracardiac extension. The patient was treated with personalized Conclusions: PRRT with

Indexed as

Heart NeoplasmsHumansMaleMiddle AgedOctreotideOrganometallic CompoundsParagangliomaPrognosisRadiopharmaceuticalslutetium Lu 177 dotatateOctreotideOrganometallic CompoundsRadiopharmaceuticals177Lu-DOTATATEdosimetrymetastatic cardiac paragangliomapersonalized activityPRRT

Identifiers

PMID34367072
PMCPMC8339957
OpenAlexW3183453894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.